Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Manali Kamdar

University of Colorado

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (13)

John C. Byrd

UPMC Hillman Cancer Center

UNITED STATES

View details

Stephan Mielke

Professor of Hematology and Cell Therapy

Karolinska Institutet

SWEDEN

View details

Arash Ash Alizadeh

Professor of Medicine

Stanford University School of Medicine

UNITED STATES

View details

Julia Vermylen

Associate Professor of Medicine

Northwestern University

UNITED STATES

View details

Maria Silveira

Associate Professor

University of Michigan

UNITED STATES

View details

Veronika Bachanova

Faculty, Professor

University of Minnesota

UNITED STATES

View details

Marie Hu

Faculty, Assistant Professor

University of Minnesota

UNITED STATES

View details

Ambuj Kumar

University of South Florida

UNITED STATES

View details

Mark Girton

Clinical Assistant Professor

University of Michigan

UNITED STATES

View details

Susan O’Brien

University of California, Irvine

UNITED STATES

View details

Koji Izutsu

Chief, Department of Hematology

National Cancer Center Hospital

JAPAN

View details

Jennifer Temel

Massachusetts General Hospital

UNITED STATES

View details

Ajay Major

Assistant Professor of Medicine

University of Colorado School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manali Kamdar

Research Interests

Explore related searches

Articles (20)

Long-term survival with lisocabtagene maraleucel in second-line large B-cell lymphoma from TRANSFORM

Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.

Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study

Crossing the trial-practice chasm in CAR-T for relapsed LBCL

From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma

DA-R-EPOCH May Mitigate the Adverse Prognostic Implication of the Diagnosis-to-Treatment Interval (DTI) in Large B-Cell Lymphomas

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naive chronic lymphocytic leukemia (Dec, 10.1038/s41375-024-02487-1, 2024)

Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study

High-Grade B-Cell Lymphoma, Not Otherwise Specified: CNS Involvement and Outcomes in a Multi-Institutional Series

Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies

Telehealth vs In-Person Early Palliative Care for Patients with Advanced Lung Cancer: A Multisite Randomized Clinical Trial

Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation

A Digital Therapeutic Application (ePAL) to Manage Pain in Patients With Advanced Cancer: A Randomized Controlled Trial

CARs to the rescue: rare aggressive lymphoma gets a power up.

At the Cutting Edge: Novel Agents in Hodgkin Lymphoma and the Evolving Role of Radiation Therapy.

Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy.

Attitudes and Beliefs Regarding Pain Medicine: Results of a National Palliative Physician Survey.

Collaborators (13)

John C. Byrd

Stephan Mielke

Arash Ash Alizadeh

Julia Vermylen

Maria Silveira

Veronika Bachanova

Marie Hu

Ambuj Kumar

Mark Girton

Susan O’Brien

Koji Izutsu

Jennifer Temel

Ajay Major

Make your next move.